Lynparza 100 mg film-coated tablets, CYCLOPHOSPHAMIDE, Lynparza 150 mg film-coated tablets, DOCETAXEL, DOXORUBICIN, CARBOPLATIN, EPIRUBICIN
ABCSG 45
Phase 2 small_molecule active
Quick answer
Lynparza 100 mg film-coated tablets, CYCLOPHOSPHAMIDE, Lynparza 150 mg film-coated tablets, DOCETAXEL, DOXORUBICIN, CARBOPLATIN, EPIRUBICIN for Early invasive triple negative breast cancer with positive HRD status (acc. to Myriad mychoice© test) is a Phase 2 program (small_molecule) at Rein Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Rein Therapeutics
- Indication
- Early invasive triple negative breast cancer with positive HRD status (acc. to Myriad mychoice© test)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active